| NASDAQ (NMS) Exchange | United States Country |
This fund is designed for investors looking to diversify their portfolio with small capitalization growth stocks. It specifically allocates at least 80% of its net assets, plus any borrowings for investment purposes, to equity securities. These securities are of companies that, at the time of the investment, fall within the market capitalization range of the Russell 2000 Growth Index. This focus allows the fund to target the swift growth potential of small-cap companies. Additionally, by earmarking at least 25% of its total assets to technology companies within the medical and information sectors, the fund positions itself at the intersection of innovation and growth, aiming to leverage the burgeoning potential in these technological frontiers.
These investments target companies that match the market capitalization criteria of the Russell 2000 Growth Index. This approach is designed for investors who seek exposure to the growth potential of small-cap companies, which are often characterized by their ability to innovate and rapidly adapt to changes in the market.
A minimum of 25% of the fund’s total assets are invested in the technology sector, with a specific focus on companies that are innovating in the fields of medicine and information. This not only diversifies the investment pool but also capitalizes on two of the fastest-growing sectors in the technology industry, aiming to yield higher returns by investing in the future of these critical areas.